In recent years, patent enforcement between operating companies has been overshadowed by non-practicing entity litigation. The Patent Trial and Appeal Board (PTAB) loomed large as a ...
A new study published in the Strategic Management Journal sheds light on how multinational firms make strategic decisions ...
Judge Pauline Newman has served with distinction on the U.S. Court of Appeals for the Federal Circuit since her appointment ...
An expert Q&A on the US Patent and Trademark Office’s (USPTO’s) 2025 guidance memoranda addressing the Patent Trial and Appeal Board’s (PTAB’s) approach to discretionary denials of inter partes review ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
According to Canadian Solar, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) has ruled in its favor, stating that “all claims asserted by Maxeon ...
Barnes & Thornburg attorneys Lauren Baker and John W. Cox examine the practical uses, benefits, and challenges of using ...
Adeia Inc. (Nasdaq: ADEA), a technology licensing firm, has initiated a major legal battle against Advanced Micro Devices, Inc. (AMD), alleging that the chip giant has infringed on ten of its ...
The Rise of ‘Settled Expectations’ In USPTO Review and the Fallout for Patent Owners and Challengers
The landscape for discretionary denials at PTAB is evolving quickly; both patent challengers and owners must adapt their strategies to ensure they are not left behind by the USPTO’s new approach. The ...
United Therapeutics Corporation (UTHR) has filed a lawsuit against Liquidia Corporation in the U.S. District Court for the Middle District of North Carolina, claiming that Liquidia infringes on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback